Neutropenia pathophysiology: Difference between revisions
Line 27: | Line 27: | ||
'''3) Peripheral destruction''' | '''3) Peripheral destruction''' | ||
- Autoimmune hemolysis | - Autoimmune [[hemolysis]] | ||
- Drug-induced hemolysis | - Drug-induced [[hemolysis]] | ||
==References== | ==References== |
Revision as of 13:03, 26 September 2016
Neutropenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neutropenia pathophysiology On the Web |
American Roentgen Ray Society Images of Neutropenia pathophysiology |
Risk calculators and risk factors for Neutropenia pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Pathophysiology
Neutropenia develops as a result of one of the three following mechanisms:
1) Impaired granulocyte production
- Hematologic malignancy with bone marrow infiltration
- Myelosuppressive chemotherapy or other medications that are toxic to the bone marrow
- Nutritional deficiencies
2) Margination (process where free flowing blood cells exit circulation)
- Splenic sequestration
- Adherence to the vascular endothelium
3) Peripheral destruction
- Autoimmune hemolysis
- Drug-induced hemolysis